Steven Rodems

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Therapeutics Development for Alagille Syndrome”.

Therapeutics Development for Alagille Syndrome

Frontiers in Pharmacology(2021)10.3389/fphar.2021.704586

N/A

0DataRank · unranked

14 citations

Atena Farkhondeh, Ivan Pavlinov, Karsten Baumgaertel, Steven Rodems, Wei Zheng +1 more

High-throughput protein modification quantitation analysis using intact protein MRM and its application on hENGase inhibitor screening

Talanta(2021)10.1016/j.talanta.2021.122384

N/A

0DataRank · unranked

6 citations

Miao Xu, Atena Farkhondeh, Andrew P. Burns, Steven Rodems, Matthew Might +3 more

Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1

Stem Cell Research(2021)10.1016/j.scr.2021.102447

N/A

0DataRank · unranked

4 citations

Manisha Pradhan, Yu‐Shan Cheng, Kirill Gorshkov, Atena Farkhondeh, Catherine Z. Chen +6 more

Generation of Alagille syndrome derived induced pluripotent stem cell line carrying heterozygous mutation in the JAGGED-1 gene at splicing site (Chr20: 10,629,709C>A) before exon 11

Stem Cell Research(2021)10.1016/j.scr.2021.102366

N/A

0DataRank · unranked

3 citations

Yu‐Shan Cheng, Miao Xu, Atena Farkhondeh, Jeanette Beers, Jizhong Zou +5 more

Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9

Stem Cell Research(2021)10.1016/j.scr.2021.102554

N/A

0DataRank · unranked

3 citations

Atena Farkhondeh, Shu Yang, Miao Xu, Yu‐Shan Cheng, Jeanette Beers +7 more

An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene

Stem Cell Research(2021)10.1016/j.scr.2021.102400

N/A

0DataRank · unranked

1 citations

Atena Farkhondeh, Yu‐Shan Cheng, Miao Xu, Jeanette Beers, Jizhong Zou +6 more

Corrigendum to “Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9” [Stem Cell Res. 56 (2021) 102554]

Stem Cell Research(2021)10.1016/j.scr.2021.102602

N/A

0DataRank · unranked

0 citations

Atena Farkhondeh, Shu Yang, Miao Xu, Yu‐Shan Cheng, Jeanette Beers +7 more

An Induced Pluripotent Stem Cell‐Derived Neuromuscular Junction Platform for Study of the NGLY1‐Congenital Disorder of Deglycosylation

Advanced Therapeutics(2022)10.1002/adtp.202200009

N/A

0DataRank · unranked

2 citations

Ashley L. Robertson, Roxana Mendez, Tristan T. Hays, Ethan Smith, Helena B. Cooper +11 more

Generation and characterization of NGLY1 patient-derived midbrain organoids

Frontiers in Cell and Developmental Biology(2023)10.3389/fcell.2023.1039182

N/A

0DataRank · unranked

16 citations

Mitali A. Tambe, Ivan Pavlinov, Atena Farkhondeh, Ha Nam Nguyen, Miao Xu +7 more

Generation of an Alagille Syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi036-A) carrying a heterozygous mutation (p.Cys693*) in the JAG1 gene

Stem Cell Research(2024)10.1016/j.scr.2024.103429

N/A

0DataRank · unranked

2 citations

Miao Xu, Ivan Pavlinov, Kaari L. Linask, Jeanette Beers, Jizhong Zou +8 more